Pharmacy Benefit Managers Report Significant Decrease in Trends for 2015
It’s that time of year again, the time when Pharmacy Benefit Managers (PBMs) release their annual drug trend analyses for the prior year. To the surprise of many, the two largest PBMs in the country, CVS Caremark (CVS) and Express Scripts (ESI), reported 2015 trends at less than half of 2014 trends. CVS reported their annual trend at 5.0% while ESI reported a trend of 5.2%. Compare these trends to the approximate 12% trend reported in 2014 – a shocker right? According to CVS, brand-name drug inflation drove to 80% of aggregate drug trend.
Let’s break these numbers down a bit more. ESI reported that specialty drugs trended at 17.8% while non-specialty drugs trended at -0.1%. High specialty drug trends are nothing new and are here to stay. You should expect specialty drug trends to remain around 17% and drive an overall drug trend of roughly 7.5% over the next several years.